Gastrointestinal Pathogen Testing Market Report 2026

Gastrointestinal Pathogen Testing Market Overview

• Gastrointestinal Pathogen Testing market size has reached to $4.23 billion in 2025 • Expected to grow to $5.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.5% • Growth Driver: Impact Of Foodborne Diseases On The Gastrointestinal Pathogen Testing Market • Market Trend: Advancements In Gastrointestinal Pathogen Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Pathogen Testing Market?

Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders. The main types of pathogens included in gastrointestinal pathogen testing include bacteria, viruses, and parasites. Bacteria are tiny organisms that can cause illness in the digestive system. Several types of tests are involved, such as molecular tests, culture, biochemical tests, and others, with various panel types included, such as syndromic full multiplex panels and others. These are used by several end-users, including hospitals, diagnostic laboratories, point-of-care, and others.

What Is The Gastrointestinal Pathogen Testing Market Growth Forecast?

The gastrointestinal pathogen testing market size is expected to see steady growth in the next few years. It will grow to $5.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to growth in syndromic testing panels, expansion of point-of-care diagnostics, demand for faster turnaround times, integration of molecular diagnostics, rising infectious disease awareness. Major trends in the forecast period include rising use of multiplex molecular diagnostic panels, increased demand for rapid stool testing, expansion of point-of-care gi diagnostics, growing adoption of pcr-based testing, enhanced focus on infection surveillance.

Global Gastrointestinal Pathogen Testing Market Segmentation

1) By Pathogen Type: Bacteria, Viruses, Parasites 2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types 3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types 4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users Subsegments: 1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens 2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens 3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

What Are The Drivers Of The Gastrointestinal Pathogen Testing Market?

The rising incidences of foodborne disease are expected to propel the growth of the gastrointestinal pathogen testing market going forward. Foodborne diseases are illnesses caused by consuming food or beverages contaminated with pathogenic microorganisms, toxins, or chemical substances. Foodborne diseases include listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The rise in foodborne incidents is due to various factors, including changes in food production, distribution, and consumption patterns, inadequate food safety measures, and climate change impacts on food production. Gastrointestinal testing helps in identifying the specific pathogens responsible for foodborne illnesses to help healthcare providers identify the cause of gastrointestinal symptoms, determine appropriate treatment, track outbreaks, and implement preventive measures to reduce the spread of foodborne diseases. For instance, in September 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that during 2023, the CDC, with state and regulatory public health partners, investigated 181 possible multistate outbreaks, of which 84 were determined to be outbreaks. Of these, outbreak investigators solved 50 outbreaks (60%). A suspected source was identified for 22 outbreaks, and a confirmed source was identified for 28 outbreaks. Therefore, the rising incidences of foodborne diseases are driving the growth of the gastrointestinal pathogen testing industry. The rising antimicrobial resistance is expected to propel the growth of the gastrointestinal pathogen testing market going forward. Antimicrobial resistance refers to the ability of bacteria, viruses, and other microorganisms to withstand the effects of drugs that were previously effective against them. The demand for gastrointestinal pathogen testing is increasing due to the growing prevalence of drug-resistant gastrointestinal infections, which require rapid and accurate detection to guide effective treatment and prevent further spread. For instance, in October 2025, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that it presents a global analysis of antibiotic resistance prevalence and trends, drawing on more than 23 million bacteriologically confirmed cases of bloodstream infections, urinary tract infections, gastrointestinal infections, and urogenital gonorrhea. Data were reported by 104 countries in 2023. Therefore, rising antimicrobial resistance is expected to drive the gastrointestinal pathogen testing industry.

Key Players In The Global Gastrointestinal Pathogen Testing Market

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Global Gastrointestinal Pathogen Testing Market Trends and Insights

Major companies operating in the gastrointestinal pathogen testing market are focusing on developing advanced solutions, such as metagenomic diagnostic tests, to enhance the accuracy, speed, and comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test is an advanced technology used to analyze the genetic material of microorganisms present in a sample, such as stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test designed to identify a wide range of gastrointestinal pathogens with unparalleled accuracy. MetaPanel covers 175 pathogen targets in a single test, offering healthcare professionals a comprehensive solution for diagnosing both common and hard-to-detect infections. It uses next-generation sequencing (NGS) technology to analyze a broad range of genetic material in a stool sample. This allows for the detection of a wide variety of potential pathogens, including those not routinely tested for in traditional GI (gastrointestinal) panels.

Regional Outlook

North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testing market consists of revenues earned by entities by providing services, such as molecular testing, culture and sensitivity testing, and rapid diagnostics tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal pathogen testing market also includes sales of testing kits, laboratory equipment, and PCR (Polymerase Chain Reaction) machines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Pathogen Testing Market Report 2026?

The gastrointestinal pathogen testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal pathogen testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.